156 related articles for article (PubMed ID: 33428484)
1. Hysteroscopic management of endometrial polyps and submucous leiomyomas in women using a levonorgestrel-releasing intrauterine system.
Kuzel D; Lisa Z; Fanta M; Zizka Z; Boudova B; Cindrova-Davies T; Mara M
Minim Invasive Ther Allied Technol; 2022 Apr; 31(4):615-619. PubMed ID: 33428484
[TBL] [Abstract][Full Text] [Related]
2. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.
Romero SA; Young K; Hickey M; Su HI
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD007245. PubMed ID: 33348436
[TBL] [Abstract][Full Text] [Related]
3. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.
Dominick S; Hickey M; Chin J; Su HI
Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD007245. PubMed ID: 26649916
[TBL] [Abstract][Full Text] [Related]
4. Hysteroscopic management of displaced levonorgestrel-releasing intrauterine system.
Kuzel D; Hrazdirova L; Kubinova K; Dundr P; Cibula D; Mara M
J Obstet Gynaecol Res; 2013 May; 39(5):1014-8. PubMed ID: 23496334
[TBL] [Abstract][Full Text] [Related]
5. Prevention of Benign Endometrial Polyp Recurrence Using a Levonorgestrel-releasing Intrauterine System in Premenopausal Patients: A Retrospective Cohort Study.
Wang Y; Yang M; Huang X; Li X; Lin E; Feng Y
J Minim Invasive Gynecol; 2020; 27(6):1281-1286. PubMed ID: 32446971
[TBL] [Abstract][Full Text] [Related]
6. Treatment of Women With an Endometrial Polyp and Heavy Menstrual Bleeding: A Levonorgestrel-Releasing Intrauterine Device or Hysteroscopic Polypectomy?
van Dijk MM; van Hanegem N; de Lange ME; Timmermans A
J Minim Invasive Gynecol; 2015; 22(7):1153-62. PubMed ID: 26151760
[TBL] [Abstract][Full Text] [Related]
7. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.
Chin J; Konje JC; Hickey M
Cochrane Database Syst Rev; 2009 Oct; (4):CD007245. PubMed ID: 19821400
[TBL] [Abstract][Full Text] [Related]
8. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.
Lethaby AE; Cooke I; Rees M
Cochrane Database Syst Rev; 2005 Oct; (4):CD002126. PubMed ID: 16235297
[TBL] [Abstract][Full Text] [Related]
9. Uterine volume and menstrual patterns in users of the levonorgestrel-releasing intrauterine system with idiopathic menorrhagia or menorrhagia due to leiomyomas.
Magalhães J; Aldrighi JM; de Lima GR
Contraception; 2007 Mar; 75(3):193-8. PubMed ID: 17303488
[TBL] [Abstract][Full Text] [Related]
10. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.
Lethaby A; Hussain M; Rishworth JR; Rees MC
Cochrane Database Syst Rev; 2015 Apr; (4):CD002126. PubMed ID: 25924648
[TBL] [Abstract][Full Text] [Related]
11. Emerging indications for the levonorgestrel-releasing intrauterine system (LNG-IUS).
Heikinheimo O; Gemzell-Danielsson K
Acta Obstet Gynecol Scand; 2012 Jan; 91(1):3-9. PubMed ID: 22007693
[TBL] [Abstract][Full Text] [Related]
12. Malignant endometrial polyp in woman with the levonorgestrel intrauterine system - a case report.
Kuzel D; Mara M; Zizka Z; Koliba P; Dundr P; Fanta M
Gynecol Endocrinol; 2019 Feb; 35(2):112-114. PubMed ID: 30449212
[TBL] [Abstract][Full Text] [Related]
13. Levonorgestrel releasing-intrauterine system for the treatment of menorrhagia and/or frequent irregular uterine bleeding associated with uterine leiomyoma.
Socolov D; Blidaru I; Tamba B; Miron N; Boiculese L; Socolov R
Eur J Contracept Reprod Health Care; 2011 Dec; 16(6):480-7. PubMed ID: 21942657
[TBL] [Abstract][Full Text] [Related]
14. Use of a levonorgestrel 52-mg intrauterine system in the control of abnormal uterine bleeding in women with inherited bleeding disorders.
Campos RR; Baêta T; Silva-Filho A; Rezende SM; Rocha ALL
Contraception; 2020 Oct; 102(4):254-258. PubMed ID: 32470465
[TBL] [Abstract][Full Text] [Related]
15. The effect on menstrual blood loss in women with uterine fibroids of a novel "frameless" intrauterine levonorgestrel-releasing drug delivery system: a pilot study.
Wildemeersch D; Schacht E
Eur J Obstet Gynecol Reprod Biol; 2002 Apr; 102(1):74-9. PubMed ID: 12039094
[TBL] [Abstract][Full Text] [Related]
16. Endometrial ablation or resection versus levonorgestrel intra-uterine system for the treatment of women with heavy menstrual bleeding and a normal uterine cavity: a systematic review with meta-analysis.
Bergeron C; Laberge PY; Boutin A; Thériault MA; Valcourt F; Lemyre M; Maheux-Lacroix S
Hum Reprod Update; 2020 Feb; 26(2):302-311. PubMed ID: 31990359
[TBL] [Abstract][Full Text] [Related]
17. Use of a levonorgestrel-releasing intrauterine system to treat bleeding related to uterine leiomyomas.
Grigorieva V; Chen-Mok M; Tarasova M; Mikhailov A
Fertil Steril; 2003 May; 79(5):1194-8. PubMed ID: 12738516
[TBL] [Abstract][Full Text] [Related]
18. Bleeding pattern and user satisfaction in second consecutive levonorgestrel-releasing intrauterine system users: results of a prospective 5-year study.
Heikinheimo O; Inki P; Schmelter T; Gemzell-Danielsson K
Hum Reprod; 2014 Jun; 29(6):1182-8. PubMed ID: 24682613
[TBL] [Abstract][Full Text] [Related]
19. [Effects of levonorgestrel intrauterine system on endometrial tissue after endometrial polyps resection by hysteroscopy].
Cai HL; Ding XC; Qian RR; Yu RF; Sun LM; Li Q
Zhonghua Yi Xue Za Zhi; 2012 Jan; 92(3):200-2. PubMed ID: 22490745
[TBL] [Abstract][Full Text] [Related]
20. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
